IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q3 2019 Holdings

Filed 2019-11-13 | 5 holdings | $16.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc(ADMA)COM000899104$16.1M3,608,17199.8%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$26.0K1,240,0000.2%
Cidara Therapeutics Inc.COM171757107$1.8K891,6140.0%
Transenterix Inc.COM NEW89366M201$1.5K2,389,3520.0%
Viewray Inc.(VRAYQ)COM92672L107$018,9640.0%